nodes	percent_of_prediction	percent_of_DWPC	metapath
Milrinone—Arrhythmia supraventricular—Pemetrexed—lung cancer	0.0753	0.0753	CcSEcCtD
Milrinone—Infusion site reaction—Paclitaxel—lung cancer	0.0652	0.0652	CcSEcCtD
Milrinone—Infusion site reaction—Docetaxel—lung cancer	0.0553	0.0553	CcSEcCtD
Milrinone—Arrhythmia supraventricular—Gemcitabine—lung cancer	0.0311	0.0311	CcSEcCtD
Milrinone—Ventricular tachycardia—Pemetrexed—lung cancer	0.0292	0.0292	CcSEcCtD
Milrinone—Hypokalaemia—Crizotinib—lung cancer	0.0211	0.0211	CcSEcCtD
Milrinone—Hypokalaemia—Gefitinib—lung cancer	0.0192	0.0192	CcSEcCtD
Milrinone—Angina pectoris—Pemetrexed—lung cancer	0.0178	0.0178	CcSEcCtD
Milrinone—Liver function test abnormal—Teniposide—lung cancer	0.0159	0.0159	CcSEcCtD
Milrinone—Bronchospasm—Teniposide—lung cancer	0.0146	0.0146	CcSEcCtD
Milrinone—Arrhythmia—Crizotinib—lung cancer	0.0143	0.0143	CcSEcCtD
Milrinone—Arrhythmia—Pemetrexed—lung cancer	0.0131	0.0131	CcSEcCtD
Milrinone—Arrhythmia—Gefitinib—lung cancer	0.013	0.013	CcSEcCtD
Milrinone—Hypokalaemia—Erlotinib—lung cancer	0.0115	0.0115	CcSEcCtD
Milrinone—Ventricular extrasystoles—Paclitaxel—lung cancer	0.0112	0.0112	CcSEcCtD
Milrinone—Angina pectoris—Vinblastine—lung cancer	0.011	0.011	CcSEcCtD
Milrinone—Chest pain—Pemetrexed—lung cancer	0.0109	0.0109	CcSEcCtD
Milrinone—Arrhythmia—Teniposide—lung cancer	0.0106	0.0106	CcSEcCtD
Milrinone—Anaphylactic shock—Pemetrexed—lung cancer	0.0104	0.0104	CcSEcCtD
Milrinone—Thrombocytopenia—Pemetrexed—lung cancer	0.0102	0.0102	CcSEcCtD
Milrinone—Thrombocytopenia—Gefitinib—lung cancer	0.0101	0.0101	CcSEcCtD
Milrinone—Ventricular tachycardia—Paclitaxel—lung cancer	0.0101	0.0101	CcSEcCtD
Milrinone—Hypotension—Gefitinib—lung cancer	0.00967	0.00967	CcSEcCtD
Milrinone—Bronchospasm—Vinorelbine—lung cancer	0.00926	0.00926	CcSEcCtD
Milrinone—Angina pectoris—Vinorelbine—lung cancer	0.00917	0.00917	CcSEcCtD
Milrinone—Chest pain—Teniposide—lung cancer	0.0088	0.0088	CcSEcCtD
Milrinone—Thrombocytopenia—Teniposide—lung cancer	0.00826	0.00826	CcSEcCtD
Milrinone—Hypokalaemia—Irinotecan—lung cancer	0.00817	0.00817	CcSEcCtD
Milrinone—Liver function test abnormal—Gemcitabine—lung cancer	0.00807	0.00807	CcSEcCtD
Milrinone—Hypokalaemia—Gemcitabine—lung cancer	0.00796	0.00796	CcSEcCtD
Milrinone—Hypotension—Teniposide—lung cancer	0.00789	0.00789	CcSEcCtD
Milrinone—Arrhythmia—Erlotinib—lung cancer	0.00778	0.00778	CcSEcCtD
Milrinone—Angina pectoris—Irinotecan—lung cancer	0.00756	0.00756	CcSEcCtD
Milrinone—Bronchospasm—Gemcitabine—lung cancer	0.00744	0.00744	CcSEcCtD
Milrinone—Hypokalaemia—Cisplatin—lung cancer	0.00742	0.00742	CcSEcCtD
Milrinone—Ventricular arrhythmia—Doxorubicin—lung cancer	0.00721	0.00721	CcSEcCtD
Milrinone—Rash—Crizotinib—lung cancer	0.00719	0.00719	CcSEcCtD
Milrinone—Dermatitis—Crizotinib—lung cancer	0.00718	0.00718	CcSEcCtD
Milrinone—Liver function test abnormal—Paclitaxel—lung cancer	0.00676	0.00676	CcSEcCtD
Milrinone—Arrhythmia—Vinorelbine—lung cancer	0.00673	0.00673	CcSEcCtD
Milrinone—Hypokalaemia—Paclitaxel—lung cancer	0.00666	0.00666	CcSEcCtD
Milrinone—Rash—Pemetrexed—lung cancer	0.00657	0.00657	CcSEcCtD
Milrinone—Dermatitis—Pemetrexed—lung cancer	0.00656	0.00656	CcSEcCtD
Milrinone—Rash—Gefitinib—lung cancer	0.00653	0.00653	CcSEcCtD
Milrinone—Chest pain—Topotecan—lung cancer	0.00652	0.00652	CcSEcCtD
Milrinone—Dermatitis—Gefitinib—lung cancer	0.00652	0.00652	CcSEcCtD
Milrinone—Chest pain—Erlotinib—lung cancer	0.00646	0.00646	CcSEcCtD
Milrinone—Bronchospasm—Etoposide—lung cancer	0.00635	0.00635	CcSEcCtD
Milrinone—Thrombocytopenia—Vinblastine—lung cancer	0.0063	0.0063	CcSEcCtD
Milrinone—Anaphylactic shock—Topotecan—lung cancer	0.00625	0.00625	CcSEcCtD
Milrinone—Thrombocytopenia—Topotecan—lung cancer	0.00612	0.00612	CcSEcCtD
Milrinone—Thrombocytopenia—Erlotinib—lung cancer	0.00606	0.00606	CcSEcCtD
Milrinone—Ventricular extrasystoles—Doxorubicin—lung cancer	0.00591	0.00591	CcSEcCtD
Milrinone—Liver function test abnormal—Docetaxel—lung cancer	0.00573	0.00573	CcSEcCtD
Milrinone—Chest pain—Vinorelbine—lung cancer	0.00558	0.00558	CcSEcCtD
Milrinone—Arrhythmia—Irinotecan—lung cancer	0.00555	0.00555	CcSEcCtD
Milrinone—Arrhythmia—Gemcitabine—lung cancer	0.00541	0.00541	CcSEcCtD
Milrinone—Anaphylactic shock—Vinorelbine—lung cancer	0.00535	0.00535	CcSEcCtD
Milrinone—Ventricular tachycardia—Doxorubicin—lung cancer	0.00534	0.00534	CcSEcCtD
Milrinone—Rash—Teniposide—lung cancer	0.00532	0.00532	CcSEcCtD
Milrinone—Dermatitis—Teniposide—lung cancer	0.00532	0.00532	CcSEcCtD
Milrinone—Headache—Teniposide—lung cancer	0.00529	0.00529	CcSEcCtD
Milrinone—Bronchospasm—Docetaxel—lung cancer	0.00528	0.00528	CcSEcCtD
Milrinone—Thrombocytopenia—Vinorelbine—lung cancer	0.00524	0.00524	CcSEcCtD
Milrinone—Angina pectoris—Docetaxel—lung cancer	0.00523	0.00523	CcSEcCtD
Milrinone—Arrhythmia—Cisplatin—lung cancer	0.00504	0.00504	CcSEcCtD
Milrinone—Hypotension—Vinorelbine—lung cancer	0.005	0.005	CcSEcCtD
Milrinone—Tremor—Cisplatin—lung cancer	0.0046	0.0046	CcSEcCtD
Milrinone—Arrhythmia—Paclitaxel—lung cancer	0.00453	0.00453	CcSEcCtD
Milrinone—Chest pain—Gemcitabine—lung cancer	0.00448	0.00448	CcSEcCtD
Milrinone—Anaphylactic shock—Irinotecan—lung cancer	0.00441	0.00441	CcSEcCtD
Milrinone—Thrombocytopenia—Irinotecan—lung cancer	0.00432	0.00432	CcSEcCtD
Milrinone—Anaphylactic shock—Gemcitabine—lung cancer	0.0043	0.0043	CcSEcCtD
Milrinone—Thrombocytopenia—Gemcitabine—lung cancer	0.00421	0.00421	CcSEcCtD
Milrinone—Tremor—Paclitaxel—lung cancer	0.00413	0.00413	CcSEcCtD
Milrinone—Liver function test abnormal—Methotrexate—lung cancer	0.00413	0.00413	CcSEcCtD
Milrinone—Hypotension—Irinotecan—lung cancer	0.00412	0.00412	CcSEcCtD
Milrinone—Headache—Vinblastine—lung cancer	0.00403	0.00403	CcSEcCtD
Milrinone—Hypotension—Gemcitabine—lung cancer	0.00402	0.00402	CcSEcCtD
Milrinone—Anaphylactic shock—Cisplatin—lung cancer	0.00401	0.00401	CcSEcCtD
Milrinone—Rash—Topotecan—lung cancer	0.00394	0.00394	CcSEcCtD
Milrinone—Dermatitis—Topotecan—lung cancer	0.00394	0.00394	CcSEcCtD
Milrinone—Thrombocytopenia—Cisplatin—lung cancer	0.00392	0.00392	CcSEcCtD
Milrinone—Headache—Topotecan—lung cancer	0.00392	0.00392	CcSEcCtD
Milrinone—Rash—Erlotinib—lung cancer	0.0039	0.0039	CcSEcCtD
Milrinone—Dermatitis—Erlotinib—lung cancer	0.0039	0.0039	CcSEcCtD
Milrinone—Headache—Erlotinib—lung cancer	0.00388	0.00388	CcSEcCtD
Milrinone—Arrhythmia—Docetaxel—lung cancer	0.00384	0.00384	CcSEcCtD
Milrinone—Chest pain—Etoposide—lung cancer	0.00383	0.00383	CcSEcCtD
Milrinone—Chest pain—Paclitaxel—lung cancer	0.00375	0.00375	CcSEcCtD
Milrinone—Hypotension—Cisplatin—lung cancer	0.00374	0.00374	CcSEcCtD
Milrinone—Anaphylactic shock—Etoposide—lung cancer	0.00367	0.00367	CcSEcCtD
Milrinone—Anaphylactic shock—Paclitaxel—lung cancer	0.0036	0.0036	CcSEcCtD
Milrinone—Thrombocytopenia—Etoposide—lung cancer	0.00359	0.00359	CcSEcCtD
Milrinone—Liver function test abnormal—Doxorubicin—lung cancer	0.00358	0.00358	CcSEcCtD
Milrinone—Hypokalaemia—Doxorubicin—lung cancer	0.00353	0.00353	CcSEcCtD
Milrinone—Thrombocytopenia—Paclitaxel—lung cancer	0.00352	0.00352	CcSEcCtD
Milrinone—Hypotension—Etoposide—lung cancer	0.00343	0.00343	CcSEcCtD
Milrinone—Rash—Vinorelbine—lung cancer	0.00337	0.00337	CcSEcCtD
Milrinone—Dermatitis—Vinorelbine—lung cancer	0.00337	0.00337	CcSEcCtD
Milrinone—Hypotension—Paclitaxel—lung cancer	0.00336	0.00336	CcSEcCtD
Milrinone—Headache—Vinorelbine—lung cancer	0.00335	0.00335	CcSEcCtD
Milrinone—Angina pectoris—Doxorubicin—lung cancer	0.00326	0.00326	CcSEcCtD
Milrinone—Chest pain—Docetaxel—lung cancer	0.00318	0.00318	CcSEcCtD
Milrinone—Anaphylactic shock—Docetaxel—lung cancer	0.00305	0.00305	CcSEcCtD
Milrinone—Thrombocytopenia—Docetaxel—lung cancer	0.00299	0.00299	CcSEcCtD
Milrinone—Hypotension—Docetaxel—lung cancer	0.00285	0.00285	CcSEcCtD
Milrinone—Rash—Irinotecan—lung cancer	0.00278	0.00278	CcSEcCtD
Milrinone—Dermatitis—Irinotecan—lung cancer	0.00278	0.00278	CcSEcCtD
Milrinone—Headache—Irinotecan—lung cancer	0.00276	0.00276	CcSEcCtD
Milrinone—Rash—Gemcitabine—lung cancer	0.00271	0.00271	CcSEcCtD
Milrinone—Dermatitis—Gemcitabine—lung cancer	0.00271	0.00271	CcSEcCtD
Milrinone—Headache—Gemcitabine—lung cancer	0.00269	0.00269	CcSEcCtD
Milrinone—Rash—Cisplatin—lung cancer	0.00253	0.00253	CcSEcCtD
Milrinone—Dermatitis—Cisplatin—lung cancer	0.00252	0.00252	CcSEcCtD
Milrinone—Arrhythmia—Doxorubicin—lung cancer	0.00239	0.00239	CcSEcCtD
Milrinone—Rash—Etoposide—lung cancer	0.00231	0.00231	CcSEcCtD
Milrinone—Dermatitis—Etoposide—lung cancer	0.00231	0.00231	CcSEcCtD
Milrinone—Headache—Etoposide—lung cancer	0.0023	0.0023	CcSEcCtD
Milrinone—Chest pain—Methotrexate—lung cancer	0.00229	0.00229	CcSEcCtD
Milrinone—Rash—Paclitaxel—lung cancer	0.00227	0.00227	CcSEcCtD
Milrinone—Dermatitis—Paclitaxel—lung cancer	0.00227	0.00227	CcSEcCtD
Milrinone—Headache—Paclitaxel—lung cancer	0.00225	0.00225	CcSEcCtD
Milrinone—Anaphylactic shock—Methotrexate—lung cancer	0.0022	0.0022	CcSEcCtD
Milrinone—Thrombocytopenia—Methotrexate—lung cancer	0.00215	0.00215	CcSEcCtD
Milrinone—Hypotension—Methotrexate—lung cancer	0.00205	0.00205	CcSEcCtD
Milrinone—Chest pain—Doxorubicin—lung cancer	0.00199	0.00199	CcSEcCtD
Milrinone—Rash—Docetaxel—lung cancer	0.00192	0.00192	CcSEcCtD
Milrinone—Dermatitis—Docetaxel—lung cancer	0.00192	0.00192	CcSEcCtD
Milrinone—Headache—Docetaxel—lung cancer	0.00191	0.00191	CcSEcCtD
Milrinone—Anaphylactic shock—Doxorubicin—lung cancer	0.0019	0.0019	CcSEcCtD
Milrinone—Thrombocytopenia—Doxorubicin—lung cancer	0.00186	0.00186	CcSEcCtD
Milrinone—Hypotension—Doxorubicin—lung cancer	0.00178	0.00178	CcSEcCtD
Milrinone—Rash—Methotrexate—lung cancer	0.00139	0.00139	CcSEcCtD
Milrinone—Dermatitis—Methotrexate—lung cancer	0.00138	0.00138	CcSEcCtD
Milrinone—Headache—Methotrexate—lung cancer	0.00138	0.00138	CcSEcCtD
Milrinone—Rash—Doxorubicin—lung cancer	0.0012	0.0012	CcSEcCtD
Milrinone—Dermatitis—Doxorubicin—lung cancer	0.0012	0.0012	CcSEcCtD
Milrinone—Headache—Doxorubicin—lung cancer	0.00119	0.00119	CcSEcCtD
